(ATDN) One anti-TB pill

(ATDN) One anti-TB pill

Treatment Review No. 13; August 1994

The U.S. Food and Drug Administration has granted approval of Rifater, a combination of three drugs, for the treatment of tuberculosis. Standard treatment for TB requires someone with TB to take up to 13 pills daily. When symptoms improve, some people stop taking their medications. Treatment for TB infection has to continue for up to 2 years. It is very important to complete the treatment. Stopping treatment can lead to TB infections that are even more difficult to control. Rifater, a combination of rifampin, isoniazid, and pyrazinamide, requires only about six daily doses. All three drugs are standard treatments for TB. Taking one pill instead of three will make it easier for people to keep with their treatment for the length of time necessary. The drug company that makes Rifater plans to begin selling the pill this summer.

940801
ATR01304

Always watch for outdated information. This article first appeard in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

Copyright © 1994 - AIDS Treatment Data Network. If you want to copy, reproduce or excerpt this information, please give us a call at (800) 734-7104. This helps up to keep track of where and how this information is being used. You can also Email us at network@atdn.org http://206.179.124.69/network/index.html

This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1994. AEGIS.